Literature DB >> 19885289

A review of the management of implanted medical devices for diabetes: trends and directions.

Carl Edman1, Darrel Drinan.   

Abstract

The management of diabetes is progressing rapidly from the use of traditional finger sticks for glucose monitoring and multiple daily injections of insulin to more user-friendly devices and approaches. These advances hold the promise of freeing persons with diabetes from the need for continued daily compliance, thereby improving their quality of life and improving control of their underlying diabetes. An underlying theme to solutions based on percutaneous or fully implanted devices is that the useful lifetime of such devices is often limited by the body's foreign body response. This review briefly outlines general factors associated with point-in-time needle stick approaches to the growing use of short-term percutaneous implants (< or =7 days) to the challenges of more extended devices, both technical and regulatory, faced by developers of these devices.

Entities:  

Keywords:  compatibility; implanted; insulin; materials; rejection

Year:  2008        PMID: 19885289      PMCID: PMC2769818          DOI: 10.1177/193229680800200609

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  43 in total

Review 1.  Implant surfaces and interface processes.

Authors:  B Kasemo; J Gold
Journal:  Adv Dent Res       Date:  1999-06

2.  In vitro reaction of endothelial cells to polymer demixed nanotopography.

Authors:  M J Dalby; M O Riehle; H Johnstone; S Affrossman; A S G Curtis
Journal:  Biomaterials       Date:  2002-07       Impact factor: 12.479

3.  A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 diabetes.

Authors:  Ben Feldman; Ronald Brazg; Sherwyn Schwartz; Richard Weinstein
Journal:  Diabetes Technol Ther       Date:  2003       Impact factor: 6.118

4.  Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system.

Authors:  Bruce Bode; Kenneth Gross; Nancy Rikalo; Sherwyn Schwartz; Timothy Wahl; Casey Page; Todd Gross; John Mastrototaro
Journal:  Diabetes Technol Ther       Date:  2004-04       Impact factor: 6.118

5.  Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans.

Authors:  Barbara C Gilligan; Mark Shults; Rathbun K Rhodes; Peter G Jacobs; James H Brauker; Thomas J Pintar; Stuart J Updike
Journal:  Diabetes Technol Ther       Date:  2004-06       Impact factor: 6.118

6.  Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions.

Authors:  C Djakouré-Platonoff; R Radermercker; G Reach; G Slama; J I Selam
Journal:  Diabetes Metab       Date:  2003-04       Impact factor: 6.041

7.  A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

Authors:  Elizabeth A Doyle; Stuart A Weinzimer; Amy T Steffen; Jo Ann H Ahern; Miranda Vincent; William V Tamborlane
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

8.  Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.

Authors:  H Gin; E Renard; V Melki; S Boivin; P Schaepelynck-Bélicar; B Guerci; J L Selam; J M Brun; J P Riveline; B Estour; B Catargi
Journal:  Diabetes Metab       Date:  2003-12       Impact factor: 6.041

9.  The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants.

Authors:  W Kenneth Ward; Emily P Slobodzian; Kenneth L Tiekotter; Michael D Wood
Journal:  Biomaterials       Date:  2002-11       Impact factor: 12.479

10.  Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes.

Authors:  Satish K Garg; Sherwyn Schwartz; Steven V Edelman
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

View more
  1 in total

1.  Dynamic actuation enhances transport and extends therapeutic lifespan in an implantable drug delivery platform.

Authors:  William Whyte; Debkalpa Goswami; Sophie X Wang; Yiling Fan; Niamh A Ward; Ruth E Levey; Rachel Beatty; Scott T Robinson; Declan Sheppard; Raymond O'Connor; David S Monahan; Lesley Trask; Keegan L Mendez; Claudia E Varela; Markus A Horvath; Robert Wylie; Joanne O'Dwyer; Daniel A Domingo-Lopez; Arielle S Rothman; Garry P Duffy; Eimear B Dolan; Ellen T Roche
Journal:  Nat Commun       Date:  2022-08-03       Impact factor: 17.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.